Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury

Schallert, T. J., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,357 · see citing works

Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression

Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994) · Nature · doi:10.1038/369486a0 · Cited by 1,083 · see citing works

A cellular mechanism of reward-related learning

Reynolds, J. N. J., Hyland, B. I., & Wickens, J. R. (2001) · Nature · doi:10.1038/35092560 · Cited by 879 · see citing works

Beyond the Dopamine Receptor

Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 748 · see citing works

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 741 · see citing works

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664 · see citing works

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA

Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.t01-1-00285.x · Cited by 615 · see citing works

DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1

Hemmings, H. C., Greengard, P., Tung, H. Y. L., & Cohen, P. (1984) · Nature · doi:10.1038/310503a0 · Cited by 613 · see citing works

Building action repertoires: memory and learning functions of the basal ganglia

Graybiel, A. M. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80100-6 · Cited by 557 · see citing works

L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNA

Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 546 · see citing works

Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

Bézard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature reviews. Neuroscience · doi:10.1038/35086062 · Cited by 501 · see citing works

Levodopa motor complications in Parkinson's disease

Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478 · see citing works

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia

Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)81862-5 · Cited by 462 · see citing works

Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels

Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00119.x · Cited by 418 · see citing works

Dopamine D-1/D-5 Receptor Activation Is Required for Long-Term Potentiation in the Rat Neostriatum In Vitro

Kerr, J. N. D., & Wickens, J. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.117 · Cited by 384 · see citing works

Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity

Calabresi, P., Gubellini, P., Centonze, D., Picconi, B., Bernardi, G., Chergui, K., Svenningsson, P., Fienberg, A. A., & Greengard, P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08443.2000 · Cited by 379 · see citing works

Reversal of long-term potentiation (depotentiation) induced by tetanus stimulation of the input to CA1 neurons of guinea pig hippocampal slices.

Fujii, S., Saito, K., Miyakawa, H., Ito, K., & Kato, H. (1991) · Brain Research · doi:10.1016/0006-8993(91)90867-u · Cited by 375 · see citing works

Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease

Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350 · see citing works

Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases.Preprint

O’Dell, T. J., & Kandel, E. R. (1994) · Learning & Memory · doi:10.1101/lm.1.2.129 · Cited by 298 · see citing works

Plasticity of Synapses in the Rat Neostriatum after Unilateral Lesion of the Nigrostriatal Dopaminergic Pathway

Ingham, C. A., Hood, S. H., Taggart, P., & Arbuthnott, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04732.1998 · Cited by 291 · see citing works

An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism

Rozas, G., Guerra, M. J., & Labandeira-García, J. L. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00034-2 · Cited by 275 · see citing works

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Chase, T. N., & Oh, J. D. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00018-5 · Cited by 250 · see citing works

Functional Activity of Substantia Nigra Grafts Reinnervating the Striatum: Neurotransmitter Metabolism and [14C]2‐Deoxy‐ d ‐glucose Autoradiography

Schmidt, R. H., Ingvar, M., Lindvall, O., Stenevi, U., & Björklund, A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb08693.x · Cited by 232 · see citing works

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution

Hemmings, H., & Greengard, P. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-05-01469.1986 · Cited by 229 · see citing works

In vivo activity-dependent plasticity at cortico-striatal connections: Evidence for physiological long-term potentiation

Charpier, S., & Deniau, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.7036 · Cited by 222 · see citing works

Unilateral Dopamine Denervation Blocks Corticostriatal LTP

Centonze, D., Gubellini, P., Picconi, B., Calabresi, P., Giacomini, P., & Bernardi, G. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3575 · Cited by 211 · see citing works

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D 1 , dopamine D 2 , and adenosine A 2A receptors

Svenningsson, P., Lindskog, M., Ledent, C. A., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1856 · Cited by 196 · see citing works

An investigation of depotentiation of longterm potentiation in the CA1 region of the hippocampus

Bashir, Z. I., & Collingridge, G. L. (1994) · Experimental Brain Research · doi:10.1007/bf02738403 · Cited by 196 · see citing works

D1/D5 Dopamine Receptors Inhibit Depotentiation at CA1 Synapses via cAMP-Dependent Mechanism

Otmakhova, N. A., & Lisman, J. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01270.1998 · Cited by 176 · see citing works

Electrophysiology of dopamine in normal and denervated striatal neurons

Calabresi, P., Centonze, D., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00017-3 · Cited by 159 · see citing works

Characterization of the Mechanism Underlying the Reversal of Long Term Potentiation by Low Frequency Stimulation at Hippocampal CA1 Synapses

Huang, C., Liang, Y., & Hsu, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106388200 · Cited by 152 · see citing works

BASAL GANGLIA DISEASE

Marsden, C. D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92797-0 · Cited by 149 · see citing works

Levodopa strengths and weaknesses

Jankovic, J. J. (2002) · Neurology · doi:10.1212/wnl.58.suppl_1.s19 · Cited by 131 · see citing works

Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?

Calabresi, P. A., Giacomini, P., Centonze, D., & Bernardi, G. (2000) · PubMed · Cited by 123 · see citing works

Progress in Understanding the Factors Regulating Reversibility of Long-term Potentiation

Huang, C., & Hsu, K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.51 · Cited by 106 · see citing works

Pathophysiology of L-dopa-induced dyskinesias.

Bédard, P. J., Blanchet, P. J., Lévesque, D., et al. (1999) · PubMed · Cited by 60 · see citing works

Fast regulation of steroid biosynthesis: a further piece in the neurosteroid puzzle

Balthazart, J., & Ball, G. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01514-3 · Cited by 34 · see citing works

Untitled work

Louis (1999) · doi:10.1002/1531-8257(199905)14:3

Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290 · see citing works

D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · see citing works

Dopamine-mediated regulation of corticostriatal synaptic plasticity

Calabresi, P., Picconi, B., Tozzi, A., & Di Filippo, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.001 · Cited by 865 · see citing works

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease

Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798 · see citing works

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · see citing works

Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum

Lovinger, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.008 · Cited by 488 · see citing works

Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice

Shmelkov, S. V., Hormigo, A., Jing, D., Proenca, C. C., Bath, K. G., Milde, T., Shmelkov, E., Kushner, J. S., Baljevic, M., Dincheva, I., et al. (2010) · Nature Medicine · doi:10.1038/nm.2125 · Cited by 361 · see citing works

Wearable Sweat Band for Noninvasive Levodopa Monitoring

Tai, L.-C., Liaw, T. S., Lin, Y., Nyein, H. Y. Y., Bariya, M., Ji, W., Hettick, M., Zhao, C., Zhao, J., Hou, L., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02478 · Cited by 177 · see citing works

Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory

Di Filippo, M., Picconi, B., Tantucci, M., Ghiglieri, V., Bagetta, V., Sgobio, C., Tozzi, A., Parnetti, L., & Calabresi, P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.025 · Cited by 158 · see citing works

Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys

Quik, M., Cox, H., Parameswaran, N., O'Leary, K., Langston, J. W., & Di Monte, D. (2007) · Annals of Neurology · doi:10.1002/ana.21203 · Cited by 133 · see citing works

Serotonin–dopamine interaction in the induction and maintenance of l-DOPA-induced dyskinesias

CARTA, M., CARLSSON, T., MUNOZ, A., KIRIK, D., & BJORKLUND, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00922-9 · Cited by 131 · see citing works

Continuous and intermittent nicotine treatment reduces l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease

Bordia, T., Campos, C., Huang, L., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140897 · Cited by 120 · see citing works

Dopaminergic modulation of striatal function and Parkinson’s disease

Zhai, S., Shen, W., Graves, S. M., & Surmeier, D. J. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01997-y · Cited by 100 · see citing works

Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease

Bagetta, V., Sgobio, C., Pendolino, V., Del Papa, G., Tozzi, A., Ghiglieri, V., Giampà, C., Zianni, E., Gardoni, F., Calabresi, P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2664-12.2012 · Cited by 74 · see citing works

Ceftriaxone reduces <scp>L</scp> ‐dopa–induced dyskinesia severity in 6‐hydroxydopamine parkinson's disease model

Chotibut, T., Meadows, S., Kasanga, E. A., McInnis, T., Cantu, M. A., Bishop, C., & Salvatore, M. F. (2017) · Movement Disorders · doi:10.1002/mds.27077 · Cited by 56 · see citing works

Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys

Morissette, M., Samadi, P., Tahar, A. H., Bélanger, N., & Di Paolo, T. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.011 · Cited by 47 · see citing works

Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by <scp>l</scp>‐DOPA in hemiparkinsonian rats

Bortolanza, M., do Nascimento, G. C., Raisman‐Vozari, R., & Del‐Bel, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15439 · Cited by 33 · see citing works

Clinical pharmacology of levodopa-induced dyskinesia.

Nutt, J. G. (2000) · PubMed · Cited by 45 · see citing works

Risk factors for levodopa-induced dyskinesia in Parkinson’s disease patients

Djuric, G., Marković, V., Pekmezovic, T. D., et al. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp150723264d · Cited by 1 · see citing works

Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease

Hashim, H., Norlinah, M. I., Nafisah, W. Y., et al. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833511 · Cited by 9 · see citing works

Levodopa-responsive retrocollis on the background of choreic dyskinesia

Kataoka, H., Sawada, Y., Shimozato, N., Inatomi, S., Yoshiji, H., & Sugie, K. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1692836 · Cited by 1 · see citing works

Levodopa-induced dyskinesia: clinical observations

Friedman, A. (1985) · Journal of Neurology · doi:10.1007/bf00314037 · Cited by 18 · see citing works